Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2016

View Archived Issues

miRagen Therapeutics and the ALS Association receive grant to develop ALS therapy

High endostatin levels may provide protective effect against cardiovascular events

Phase I study determines regimen for palbociclib with 5-fluorouracil in advanced solid tumors

Terumo launches HeartSheet in Japan

EpimAb Biotherapeutics announces agreement with Innovent Biologics

Protalix BioTherapeutics initiates global phase III study of PRX-102 in Fabry disease

GlaxoSmithKline discloses NAD-dependent SIRT1 activators

Medgenics collaborates with Kyowa Hakko Kirin on anti-LIGHT monoclonal antibody for pediatric IBD

Takeda Pharmaceutical and Roivant Sciences form Myovant Sciences

GeoVax begins HBV vaccine development program

Seres Therapeutics signs agreement with the Mayo Clinic

RealStar Zika virus test available in U.S.

Ocular Therapeutix's phase III trial of Dextenza does not meet primary endpoint

Adamis Pharmaceuticals receives FDA response on Epinephrine Injection

FDA approves Allergan's FDC Byvalson for hypertension

FDA requests further data to enable review of eteplirsen NDA

Scientists identify two novel mutations causing type I hyperlipoproteinemia

Vonosap and Vonopion packs launched in Japan for H. pylori eradication

TRX-518 is safe in patients with advanced solid tumors

Fusion peptide of HIV-1 as target for vaccine design

Targeting kynurenine pathway as promising therapeutic strategy for neurodegenerative disorders

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...